|Cantor Fitzgerald||Louise Chen|
|H.C. Wainwright & Co.||Raghuram Salvaraju|
|Maxim Group||Jason McCarthy|
|Oppenheimer & Co.||Leland Gershell|
|RBC Capital Markets||Gregory J. Renza, M.D.|
Avalo Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding the Company’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Avalo Therapeutics, Inc. or its management. Avalo Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.